{
  "trial_id": "NCT01908699",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, diagnosis of pulmonary arterial hypertension subtype, WHO functional class, 6-Minute Walk distance (6MWD), right heart cardiac catheterization findings (mean Pulmonary Arterial Pressure, Pulmonary Capillary Wedge Pressure, Pulmonary Vascular Resistance), echocardiography results, pulmonary function test results (Total Lung Capacity, Forced Expiratory Volume at one second), HIV status and CD4 lymphocyte count (if applicable), current PAH therapies, duration and dose stability of inhaled treprostinil treatment, pregnancy status (for women of child-bearing potential).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Participant's Clinical Status Per World Health Organization (WHO) Functional Class",
          "WHO functional class"
        ],
        [
          "Six-Minute Walk Distance",
          "6-Minute Walk distance (6MWD)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "N-Terminal ProB-type Natriuretic Peptide (BNP) Levels",
        "Borg Dyspnea Score"
      ],
      "remaining_candidate_features": [
        "diagnosis of pulmonary arterial hypertension subtype",
        "right heart cardiac catheterization findings (mean Pulmonary Arterial Pressure, Pulmonary Capillary Wedge Pressure, Pulmonary Vascular Resistance)",
        "echocardiography results",
        "pulmonary function test results (Total Lung Capacity, Forced Expiratory Volume at one second)",
        "HIV status and CD4 lymphocyte count (if applicable)",
        "current PAH therapies",
        "duration and dose stability of inhaled treprostinil treatment",
        "pregnancy status (for women of child-bearing potential)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, WHO functional class, 6-Minute Walk Distance (6MWD), Mean Pulmonary Arterial Pressure (PAPm), Pulmonary Capillary Wedge Pressure (PCWP), Pulmonary Vascular Resistance (PVR), Total Lung Capacity (TLC), Forced Expiratory Volume in 1 Second (FEV1), Creatinine Clearance, Child-Pugh Class,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Participant's Clinical Status Per World Health Organization (WHO) Functional Class",
          "WHO functional class"
        ],
        [
          "Six-Minute Walk Distance",
          "6-Minute Walk Distance (6MWD)"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "N-Terminal ProB-type Natriuretic Peptide (BNP) Levels",
        "Borg Dyspnea Score"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Mean Pulmonary Arterial Pressure (PAPm)",
        "Pulmonary Capillary Wedge Pressure (PCWP)",
        "Pulmonary Vascular Resistance (PVR)",
        "Total Lung Capacity (TLC)",
        "Forced Expiratory Volume in 1 Second (FEV1)",
        "Creatinine Clearance",
        "Child-Pugh Class"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, WHO Functional Class, 6-Minute Walk Distance, Pulmonary Arterial Pressure, Pulmonary Capillary Wedge Pressure, Pulmonary Vascular Resistance, Total Lung Capacity, Forced Expiratory Volume at One Second, Left Ventricular Ejection Fraction, Creatinine Clearance, Childs-Pugh Class Liver Cirrhosis, Atrial Septostomy Status, Comorbid Conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Participant's Clinical Status Per World Health Organization (WHO) Functional Class",
          "WHO Functional Class"
        ],
        [
          "Six-Minute Walk Distance",
          "6-Minute Walk Distance"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "N-Terminal ProB-type Natriuretic Peptide (BNP) Levels",
        "Borg Dyspnea Score"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Pulmonary Arterial Pressure",
        "Pulmonary Capillary Wedge Pressure",
        "Pulmonary Vascular Resistance",
        "Total Lung Capacity",
        "Forced Expiratory Volume at One Second",
        "Left Ventricular Ejection Fraction",
        "Creatinine Clearance",
        "Childs-Pugh Class Liver Cirrhosis",
        "Atrial Septostomy Status",
        "Comorbid Conditions"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), WHO functional class, 6-Minute Walk distance (6MWD), mean Pulmonary Arterial Pressure (PAPm), Pulmonary Capillary Wedge Pressure (PCWP), Pulmonary Vascular Resistance (PVR), total lung capacity (TLC), forced expiratory volume at one second (FEV1), CD4 lymphocyte count, HIV status, use of antiretroviral therapy, use of other PAH therapies, duration of PAH diagnosis, duration of inhaled treprostinil treatment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Participant's Clinical Status Per World Health Organization (WHO) Functional Class",
          "WHO functional class"
        ],
        [
          "Six-Minute Walk Distance",
          "6-Minute Walk distance (6MWD)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "N-Terminal ProB-type Natriuretic Peptide (BNP) Levels",
        "Borg Dyspnea Score"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "mean Pulmonary Arterial Pressure (PAPm)",
        "Pulmonary Capillary Wedge Pressure (PCWP)",
        "Pulmonary Vascular Resistance (PVR)",
        "total lung capacity (TLC)",
        "forced expiratory volume at one second (FEV1)",
        "CD4 lymphocyte count",
        "HIV status",
        "use of antiretroviral therapy",
        "use of other PAH therapies",
        "duration of PAH diagnosis",
        "duration of inhaled treprostinil treatment."
      ]
    }
  }
}